Owing to this resistance conferred by defective MMR, known as thiopurine tolerance, it has been suggested that thiopurines may constitute a risk factor for development of human cancer via selection of MMR-defective cells that subsequently undergo neoplastic cell transformation following the accumulation of genetic mutations caused by MSI (for review [1]). This evidence concerns the gene MRC1 and cancer.